Duncheng Wang

Title: Duncheng Wang: Innovator in Acellular-Based Therapies

Introduction

Duncheng Wang is a notable inventor based in Greenville, NC (US), recognized for his contributions to the field of acellular-based therapies. With a total of seven patents to his name, Wang has made significant strides in the modulation of immune responses through innovative therapeutic approaches.

Latest Patents

Wang's latest patents include "Acellular pro-inflammatory compositions, process for making same and methods of using same." This invention focuses on acellular-based therapies aimed at decreasing the level of regulatory T cells (Treg) and increasing the level of pro-inflammatory T cells (Th17) to enhance immune stimulation. The process involves contacting an allogeneic leukocyte population with another leukocyte population to isolate the acellular components produced. Additionally, he has developed a patent for "Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system." This disclosure pertains to cellular-based therapies that modulate the levels of Treg and pro-inflammatory T cells by administering a combination of pro-tolerogenic and pro-inflammatory preparations sequentially.

Career Highlights

Throughout his career, Duncheng Wang has worked with reputable organizations, including Canadian Blood Services. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

Wang has collaborated with notable colleagues such as Mark D. Scott and Wendy M. Toyofuku. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Duncheng Wang's innovative work in acellular-based therapies showcases his commitment to advancing medical science and improving immune modulation. His contributions through patents and collaborations highlight his significant role in the field.